Alere is down another 1.2% in after-hours trade following news that its Arriva Medical unit — the largest contract supplier for diabetes testing supplies under the Medicare National Mail Order Competitive Bid Program — has appealed a decision to revoke its Medicare billing privileges. Arrival appealed to an administrative law judge at the Centers for Medicare and Medicaid Services; it expects the appeal to be heard within 30 days and a decision within three months.